Thanks for the info, much appreciated. You too @Drum in sync...

First 14 Last

Share
Profile

Follow
Giovanni33

2,499 Posts.

639

22/06/24

20:13

Post #: 74441166
Share

Originally posted by CORNBRED: ↑

I made the trek down to the gold coast for the RIU conference - mainly the free food. Chatted to Rob briefly and I was taken aback at how cheap the drilling is at Sybella. He said it was around $350k (not including assays) for the entire 8000m AC program at Sybella, whilst their hail mary holes in the greenfields targets are coming to $500k a hit. On top of that, if they use the drill samples for met testing, they get 45% back from R&D rebates, it is just stupidly cheap and quick to drill out Sybella.

Conversely, speaking to the MMA guys (side note, I am sold on the value of the Maronan deposit now) a big challenge they are facing short term is the cost to do deep diamond driling to the spacing needed to get to indicated resource. And indicated is needed before they can publish any studies and show definitively what a monster Maronan is at current silver pricing.

So a strength for Sybella is they should be able to take this well down the development path for very little $ investment, or low dilution for holders. I've been burned badly by explorers spending $2-3m on a diamond drill program with nothing to show for it, so it is comforting that the gamble by RDM on Sybella is relatively small change compared to their cash position.

Rob did mention we need a JORC resource before government bodies will accept applications for funding support, so once they get the maiden MRE out they will be pushing hard for state and federal funding which will make the cost to progress Sybella insanely low!

Expand

Thanks for the info, much appreciated.

You too @Drum in sync thanks for the link!

RDM Price at posting: 15.5¢ Sentiment: None Disclosure: Held
7 Upvote

1 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 9 more messages in this thread...

First 14 Last

Add RDM (ASX) to my watchlist

(20min delay)
Last 11.0¢		Change 0.000(0.00%)		Mkt cap ! $32.96M

Open	High	Low	Value	Volume
11.0¢	11.0¢	11.0¢	$33	299

Buyers (Bids)

No.	Vol.	Price($)
11	331650	10.5¢

Sellers (Offers)

Price($)	Vol.	No.
11.0¢	458879	5

View Market Depth

No.	Vol.	Price($)
11	331650	0.105
12	618514	0.100
1	100000	0.099
1	10000	0.098
1	100000	0.097

Price($)	Vol.	No.
0.110	458879	5
0.115	255905	3
0.120	235000	2
0.125	41666	1
0.130	101284	2

Last trade - 13.25pm 07/10/2024 (20 minute delay)

RDM (ASX) Chart

Thanks for the info, much appreciated. You too @Drum in sync...

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks for the info, much appreciated. You too @Drum in sync...

Top Stories

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News